ArticleMetabolomics : Official journal of the Metabolomic Society2026
Untargeted urinary metabolomics reveals metabolic alterations and severity biomarkers in cardiac surgery-associated acute kidney injury.
Article in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionCardiac surgery-associated acute kidney injury (CS-AKI) is a frequent, serious complication linked to increased morbidity, mortality, and long-term kidney dysfunction. Progress in early detection and effective interventions remains limited, underscoring the need for novel biomarkers and therapeutic targets. Given the kidneys' high metabolic activity, metabolomics offers a powerful strategy to identify such markers and provide mechanistic insights.
objectivesOur goal is to investigate urinary metabolome alterations associated with CS-AKI.
methodsWe performed untargeted amine/phenol metabolomic profiling of urine samples collected within four hours post-surgery from 55 cardiac surgery patients (26 non-AKI, 29 AKI), using high-performance chemical isotope labeling and liquid chromatography-mass spectrometry (LC-MS). Multivariate analyses were applied to assess group separation and to evaluate the diagnostic performance of key metabolites.
resultsUrinary metabolomic profiles were significantly different between AKI and non-AKI patients. Of 1384 detected metabolites, 45 were differentially altered in AKI (defined by a fold change exceeding the mean ± 2 standard deviations, raw p < 0.05), with 25 metabolites annotated to known compounds. The most prominent metabolite, N-acetylputrescine (Log
conclusionsUntargeted urinary metabolomics distinguished AKI from non-AKI after cardiac surgery and identified distinct metabolic signatures associated with AKI severity. This work underscores the value of urinary metabolomics for revealing mechanistic pathways and identifying candidate biomarkers that may aid early diagnosis and monitoring of CS-AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.